date,title,source
Oct-23-18,Enanta Pharmaceuticals Announces Positive Phase 1 Results and Initiation of Phase 2a Clinical Study of EDP-938 for Respiratory Syncytial Virus,Business Wire
Oct-26-18,"Report: Developing Opportunities within Assured Guaranty, Potbelly, Enanta Pharmaceuticals, Seagate Technology, Ctrip.com International, and CyberArk Software  Future Expectations, Projections Moving into 2018",GlobeNewswire
Oct-29-18,"Enanta Pharmaceuticals to Host Conference Call on November 26 at 4:30 pm ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2018",Business Wire
Nov-07-18,Why the Earnings Surprise Streak Could Continue for Enanta Pharmaceuticals (ENTA),Zacks
Nov-19-18,Enanta Pharmaceuticals (ENTA) Expected to Beat Earnings Estimates: Should You Buy?,Zacks
